All In MedTech

Device Trial Radar · NCT00953173

HERO Study: Helping Evaluate Reduction in Obesity

Last checked: Nov 20, 2026Latest source record: Mar 8, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

671

Actual

Start

Dec 2009

Primary completion

Jul 2016

Study completion Oct 2016

Sponsor

Lead sponsor
Apollo Endosurgery, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Aug 6, 2009

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A prospective, international, multi-center study of clinical outcomes and estimated healthcare resource expenditures associated with the treatment of obesity using the LAP-BAND AP® Adjustable Gastric Banding System.

Conditions

  • Obesity

Interventions

  • LAP-BAND AP® Adjustable Gastric Banding SystemDevice

    The LAP-BAND AP® is a device surgically implanted via a laparoscopic procedure. It is designed to induce weight loss in severely obese patients by limiting food consumption.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. %TBWLTime frame: 5 years

Locations

6 sites in 6 countries. Site status is shown where the registry gives one.

  • Site not named

    Everett, Washington

  • Site not named

    Adelaide, South Australia, Australia

  • Site not named

    Jette, Belgium

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.